In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges

被引：177

作者：

Mout, Rubul ^{[1
]}

Ray, Moumita ^{[1
]}

Lee, Yi-Wei ^{[1
]}

Scaletti, Federica ^{[1
]}

Rotello, Vincent M. ^{[1
]}

机构：

[1] Univ Massachusetts, Dept Chem, 710 North Pleasant St, Amherst, MA 01003 USA

来源：

BIOCONJUGATE CHEMISTRY | 2017年 / 28卷 / 04期

关键词：

MUSCULAR-DYSTROPHY; MEDIATED DELIVERY; MOUSE MODEL; HUMAN-CELLS; GENOME; CAS9; RNA; CRISPR-CAS9; NUCLEASES; ENDONUCLEASE;

D O I：

10.1021/acs.bioconjchem.7b00057

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The successful use of clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9-based gene editing for therapeutics requires efficient in vivo delivery of the CRISPR components. There are, however, major challenges on the delivery front. In this Topical Review, we will highlight recent developments in CRISPR delivery, and we will present hurdles that still need to be overcome to achieve effective in vivo editing.

引用

页码：880 / 884

页数：5

共 50 条

[1] Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications
Mills, Emily M.
Barlow, Victoria L.
Luk, Louis Y. P.
Tsai, Yu-Hsuan
CELL BIOLOGY AND TOXICOLOGY, 2020, 36 (01) : 17 - 29
[2] Delivery of CRISPR/Cas9 for therapeutic genome editing
Xu, Xiaojie
Wan, Tao
Xin, Huhu
Li, Da
Pan, Hongming
Wu, Jun
Ping, Yuan
JOURNAL OF GENE MEDICINE, 2019, 21 (07)
[3] CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential
Blenke, Erik Oude
Evers, Martijn J. W.
Mastrobattista, Enrico
van der Oost, John
JOURNAL OF CONTROLLED RELEASE, 2016, 244 : 139 - 148
[4] Therapeutic gene editing in haematological disorders with CRISPR/Cas9
Jensen, Trine I.
Axelgaard, Esben
Bak, Rasmus O.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 821 - 835
[5] Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
LaFountaine, Justin S.
Fathe, Kristin
Smyth, Hugh D. C.
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (01) : 180 - 194
[6] CRISPR/Cas9 gene-editing strategies in cardiovascular cells
Vermersch, Eva
Jouve, Charlene
Hulot, Jean-Sebastien
CARDIOVASCULAR RESEARCH, 2020, 116 (05) : 894 - 907
[7] CRISPR/CAS9, the King of Genome Editing Tools
Bannikov, A. V.
Lavrov, A. V.
MOLECULAR BIOLOGY, 2017, 51 (04) : 514 - 525
[8] CRISPR/Cas9 Technology for Non-Coding Gene Editing in Schizophrenia Therapeutics: The Recent Progress And Challenges
Mittal, Khushi Raj
Jain, Nandini Kumar
Mittal, Swati
Jain, Chakresh Kumar
CURRENT PSYCHIATRY RESEARCH AND REVIEWS, 2024, 20 (02) : 125 - 134
[9] Delivery methods for CRISPR/Cas9 gene editing in crustaceans
Xu, Sen
Pham, Thinh
Neupane, Swatantra
MARINE LIFE SCIENCE & TECHNOLOGY, 2020, 2 (01) : 1 - 5
[10] Gene editing in mouse zygotes using the CRISPR/Cas9 system
Wefers, Benedikt
Bashir, Sanum
Rossius, Jana
Wurst, Wolfgang
Kuehn, Ralf
METHODS, 2017, 121 : 55 - 67

← 1 2 3 4 5 →